AIMTM Technology - Strong Preclinical Data                                      
  1. Mice were injected on Day 1 with lung tumor cells.
  2. On Day 3, a subset of the mice was injected with tumor-specific T cells.
  3. On days 4, 5, and 6, aAPCs were injected into a subset of the mice that received tumor-specific T cells.
The results are depicted in the graph at right